Related references
Note: Only part of the references are listed.Evolution toward high-level fluoroquinolone resistance in Francisella species
Vivien Sutera et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Francisella tularensis Subspecies holarctica Occurs in Swedish Mosquitoes, Persists Through the Developmental Stages of Laboratory-Infected Mosquitoes and Is Transmissible During Blood Feeding
J. Thelaus et al.
MICROBIAL ECOLOGY (2014)
Metabolic Network Analysis-Based Identification of Antimicrobial Drug Targets in Category A Bioterrorism Agents
Yong-Yeol Ahn et al.
PLOS ONE (2014)
Experimental Infection of Voles with Francisella tularensis Indicates Their Amplification Role in Tularemia Outbreaks
Heidi Rossow et al.
PLOS ONE (2014)
A new dye uptake assay to test the activity of antibiotics against intracellular Francisella tularensis
Vivien Sutera et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2014)
New therapeutic approaches for treatment of tularaemia: a review
Sandrine Boisset et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2014)
Uncovering the components of the Francisella tularensis virulence stealth strategy
Bradley D. Jones et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2014)
Bis-indolic compounds as potential new therapeutic alternatives for tularaemia
Yvan Caspar et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2014)
The potential of liposorne-encapsulated ciprofloxacin as a tularemia therapy
Karleigh A. Hamblin et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2014)
Francisella tularensis subsp tularensis Group A.I, United States
Dawn N. Birdsell et al.
EMERGING INFECTIOUS DISEASES (2014)
Antimicrobial susceptibility of Francisella tularensis subsp holarctica strains from Hungary, Central Europe
Zsuzsa Kreizinger et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Rapid Countermeasure Discovery against Francisella tularensis Based on a Metabolic Network Reconstruction
Sidhartha Chaudhury et al.
PLOS ONE (2013)
Assessment of antimicrobial peptide LL-37 as a post-exposure therapy to protect against respiratory tularemia in mice
Helen C. Flick-Smith et al.
PEPTIDES (2013)
The use of resazurin as a novel antimicrobial agent against Francisella tularensis
Deanna M. Schmitt et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
Unique Substrates Secreted by the Type VI Secretion System of Francisella tularensis during Intramacrophage Infection
Jeanette E. Broms et al.
PLOS ONE (2012)
High-Throughput Screening of a Diversity Collection Using Biodefense Category A and B Priority Pathogens
Esther W. Barrow et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Tularemia vaccines: recent developments and remaining hurdles
J. Wayne Conlan
FUTURE MICROBIOLOGY (2011)
Phenotypic and genetic characterization of macrolide resistance in Francisella tularensis subsp. holarctica biovar I
Brieuc Gestin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Identification of ciprofloxacin resistance by SimpleProbe™, High Resolution Melt and Pyrosequencing™ nucleic acid analysis in biothreat agents: Bacillus anthracis, Yersinia pestis and Francisella tularensis
Bonnie M. Loveless et al.
MOLECULAR AND CELLULAR PROBES (2010)
Phylogeography of Francisella tularensis: Global Expansion of a Highly Fit Clone
Amy J. Vogler et al.
JOURNAL OF BACTERIOLOGY (2009)
A Real-Time PCR Array for Hierarchical Identification of Francisella Isolates
Kerstin Svensson et al.
PLOS ONE (2009)
Tularemia: current diagnosis and treatment options
Matthew J. Hepburn et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
Tularaemia:: Bioterrorism defence renews interest in Francisella tularensis
PCF Oyston et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Share Paper
